OpenLegislation

Part 9 Capital Fees for InspectionsF1

Repealed

  1. 29Fees for inspections
  2. 30Fees for inspections of pharmacovigilance service providers
  3. 31Payer of inspection fee (contract laboratories and API manufacturing sites)
  4. 32Inspections in connection with multiple applications
  5. 33Fees for inspections relating to good clinical practice in clinical trials
  6. 34Amount, and time for payment, of inspection fees in respect of an application for a wholesale dealer's licence
  7. 35Adjustment and refund of inspection fees in respect of a wholesale dealer's licence
  8. 36Amount, and time for payment, of inspection fees in respect of an application for a broker's registration or an active substance registration

Annotations

Textual amendments

F1

Regulations revoked (1.4.2016) by The Medicines (Products for Human Use) (Fees) Regulations 2016 (S.I. 2016/190), reg. 63(1) (with reg. 63(2)-(4))